NASDAQ
CNXC
Last Price
US $24.41
KEY FIGURES
MKT CAP
$1.5B
EPS
TTM
$-21.66
PEG
TTM
N/M
P/E
TTM
N/M
P/S
TTM
0.16x
YIELD
5.65%
GROWTH
Revenue Y/Y
15.80%
(FY vs FY)
EBITDA Y/Y
Cash Flow (DCF)
Fair Value
Market $24.41
290.58%
Default assumptions
EBITDA Multiple
Fair Value
Market $24.41
—
Default assumptions
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Concentrix Corporation cash flow to debt ratio of 17.40% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial stability - Healthy cash flow growth.
Concentrix Corporation's free cash flow has increased 33.53% from $428.73M last year to $572.47M, signaling increasing performance
Financial risk - Healthy debt to equity ratio.
Concentrix Corporation's debt to equity ratio is 1.70, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial risk - Healthy debt to equity ratio development.
Concentrix Corporation's debt has increased relative to shareholder equity from 1.39 last year to 1.70 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
Concentrix Corporation has negative EBITDA, making leverage ratio unreliable
Financial risk - ICR.
Concentrix Corporation's interest coverage ratio is 1.91, which means that the company struggles to meet interest obligations, signaling financial risk.
Financial risk - Profit margin growth.
Concentrix Corporation's profit margin has decreased (-610.68%) in the last year from 2.61% to -13.34%, signaling decreasing performance
Financial stability - Short term assets vs short term liabilities.
Concentrix Corporation's short-term assets of $3.08G exceed its short-term liabilities of $2.20G
Decreasing performance - ROA.
Concentrix Corporation's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Concentrix Corporation's return on equity of -37.51%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
Concentrix Corporation's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Increasing performance - Earnings stability.
Concentrix Corporation had positive net income in 4.00 out of 5 years, indicating stable and consistent earnings
Increasing performance - Free cash flow.
Concentrix Corporation has positive free cash flow, indicating the company generates cash after capital expenditures
Increasing performance - FCF yield.
Concentrix Corporation has a free cash flow yield of 37.54%, which is above the 2.00% threshold, indicating strong cash generation relative to market value
Decreasing performance - Healthy earnings growth.
Concentrix Corporation's yearly earnings has decreased -609.09% since last year from $251.22M to $-1.28G, signaling decreasing performance
Increasing performance - Healthy revenue growth.
Concentrix Corporation's yearly revenue has increased 2.15% since last year from $9.62G to $9.83G, signaling increasing performance
Increasing performance - ROIC.
ROIC 6.32% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.
Increasing performance - 3-year revenue CAGR.
Concentrix Corporation's 3-year revenue CAGR of 15.82% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Concentrix Corporation had revenue growth in 5.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Concentrix Corporation had positive ROE in 4.00 out of 5 years, indicating consistent and reliable returns on equity
Undervalued - DCF valuation.
Concentrix Corporation is undervalued relative to its fair value price of 95.34 based on Discounted Cash Flow model
Overvalued - Earnings yield.
Concentrix Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
Concentrix Corporation is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
Concentrix Corporation has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
Concentrix Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
Concentrix Corporation has a price-to-book ratio of 0.55x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Concentrix Corporation has a price-to-sales ratio of 0.15x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
-37.51%
Return on equity
ROIC: 6.32%
Valuation History
-1.2X
Price to Earnings
EV/EBITDA: -19.8X
Cash flow
Profit margin
-
(FY vs FY)
Cash flow Y/Y
11.23%
(FY vs FY)
EARNINGS FV (GRAHAM)
Fair Value
Market $24.41
1124.01%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.